Scientific article
English

Dolutegravir-based antiretroviral therapy in a severely overweight child with a multidrug-resistant human immunodeficiency virus infection. A case report and review

Published in

New microbes and new infections, vol. 6, p. 1-4

Publication date

2015

Abstract

The management of multidrug-resistant human immunodeficiency virus (MDR HIV) infections in children is particularly challenging due to the lack of experience with new drugs. Dolutegravir, combined with an optimized antiretroviral background therapy, is promising for the treatment of MDR HIV and has been approved recently for adults and adolescents. Data for children are extremely limited. We describe the efficacy, safety and plasmatic levels of a dolutegravir-based, complex active antiretroviral treatment regimen in a severely overweight 11-year-old child infected with an MDR HIV strain.

Citation (ISO format)

WAGNER, Noémie et al. Dolutegravir-based antiretroviral therapy in a severely overweight child with a multidrug-resistant human immunodeficiency virus infection. A case report and review. In: New microbes and new infections, 2015, vol. 6, p. 1–4. doi: 10.1016/j.nmni.2015.02.003

Main files (1)

Article (Published version)

Identifiers

Journal ISSN

2052-2975
628views
1downloads

Technical informations

Creation

08/09/2015 14:16:00

First validation

08/09/2015 14:16:00

Update

14/03/2023 23:42:57

Status update

14/03/2023 23:42:57

Last indexation

18/08/2025 11:30:51
All rights reserved by Archive ouverte UNIGE and the University of Geneva
OpenAIRE Indexed & Validated